Abstract. In this work we characterized a 90-kDa glycoprotein from Alzheimer disease (90Azgp) brain extracts that is recognized by the GalNAc-specific lectin from Amaranthus leucocarpus (ALL), as determined through Western blot. The 90Azgp was purified by electro-elution, and its amino acid sequence determined from peptides obtained after trypsin digestion through MALDI-TOF (Matrix-assisted laser desorption ionization-time of flight), and compared with the relative values obtained from the NCBInr (Swiss-Prot 10/01/2001) database. The 90Azgp showed 32% and 42% homology with the KIAA0310 protein from human brain and the human gastric mucin, respectively. Presence of O-glycosidically linked glycans in the proteins recognized by ALL was confirmed by inhibition of the lectin-glycoprotein interaction through hapten-inhibition assays and also by elimination of the O-glycosidically linked glycans after treatment with O-glycanase from Diplococcus pneumoniae. Electron transmission microscopy confirmed that the receptor recognized by the lectin is processed in the Golgi apparatus of AD neurons. Although the specific role of this glycoprotein has not been identified, considering that the presence of this lectin receptor co-localized with neuritic plaques and in AD sprouting neurons, it could suggest that the O-glycosylprotein identified by the A. leucocarpus lectin participates in the pathogenesis of neurodegenerative diseases.
INTRODUCTION
Alzheimer disease (AD) is characterized pathologically by the appearance of parenchymal amyloid deposits with and without neuritic elements and by intraneuronal changes, including neurofibrillary tangles and synaptic loss (1) (2) (3) . Reactive plasticity, including axonal and dendritic sprouting and reactive synaptogenesis, has been proposed to contribute to the pathogenesis of several neurological disorders (4) (5) (6) . Neuritic plaques are formed by an amyloid-␤ deposit that is surrounded by dystrophic neurites, reactive astrocytes, and microglia (7, 8) . Amyloid-␤ is a 39-42 amino acid residue cleavage product from the larger ␤-amyloid precursor protein (␤APP), a glycosylated transmembrane protein (9) . Several posttranslational modifications have been reported in ␤APP, including N-glycosylation (characterized by GlcNAc branched on Asp in a peptide backbone) and O-glycosylation (characterized by GalNAc on Ser/Thr residues), phosphorylation, and tyrosine O-sulfation (10, 11) . It has been demonstrated that an altered N-glycosylation pattern of tau and the presence of O-acetyl-neuraminic acid residues could correlate with the degree of cognitive failure in AD (12, 13) .
Previous results using lectins have suggested the presence of specific modifications in O-glycosylation in neurodegenerative diseases that were represented by different levels of complexity in O-linked oligosaccharide biosynthesis (14) . O-glycosylation is the product of multiple transferases that could be active in the presence of specific amino acid sequences (15) , suggesting the active participation of diverse proteins susceptible to O-glycosylation in the pathogenesis of AD.
Lectins with specificity for O-glycosidically linked glycans have been widely used in fractionation of glycoproteins, cellular sub-populations, and histopathology (16, 17) . The lectin from A. leucocarpus (ALL) interacts specifically with GalNAc and has been proven to be a useful tool to recognize O-glycosidically linked glycans in different tissues and cells (18) (19) (20) , and it has been recently demonstrated to interact with O-glycosidically linked proteins in some neurodegenerative processes, such as AD (13) . Recent works indicated that ALL colocalizes with anti-␤-amyloid antibodies in neuritic plaques and sprouting neurons from AD (6, 13) . To identify further and to understand the possible role of O-glycans in AD pathogenesis, we isolated the ALL receptor from AD brain-protein extracts and determined its amino acid sequence, analyzing the peptides obtained by trypsin digestion through matrix-assisted laser desorption ionization-time of flight (MALDI-TOF).
MATERIALS AND METHODS Tissue
The whole hippocampus from 7 autopsied brains, ascertained both clinically and morphologically for AD according to NINCDS-ADRDA criteria, were included in this study (21, 22) . AD patients had a mean age of 74.6 Ϯ 7.9 yr. Five nondemented control brains without any neurological impairment were used for this study (age 74 Ϯ 6.9 yr). All the tissues were sampled within 24 h after death. AD brains were fixed in 4% paraformaldehyde buffered solution. Samples were then embedded in paraffin and cut in 6-m-thick sections and prepared according to different histo-and immunohistochemistry protocols (6, 13) .
Reagents
Amaranthus leucocarpus syn hypocondriacus seeds were obtained (Tulyehualco, Mexico) and the lectin was purified by affinity chromatography on a column containing human erythrocyte type O M membranes physically entrapped in Sephadex G-25 (Sigma Chemical Co., St. Louis, MO), as described previously (18) . The ALL was labeled with the N-hydroxysuccinimide ester of biotin (Pierce Chemical Co., Rockford, IL) at a label/protein ratio of 2:1 (23). Electrophoresis and blotting reagents were obtained from Bio-Rad Lab. Inc. (Richmond, CA). Avidin-peroxidase, enzymes, sugars, O-glycanase (endo-N-acetylgalactosaminidase from Diplococcus pneumoniae), N-peptide glycosidase F (from Flavobacterium meningosepticum), and chemical reagents were from Sigma Chemical Co. Antibodies against ALL were obtained from rabbit immunized sera, as described previously (18) .
Histochemistry with ALL
Lectin histochemistry was performed using biotin-labeled lectins according to previous reports (6, 13, 24) , and lectin binding was indirectly recognized with extravidin-FITC conjugated (Sigma). Control experiments consisted of omission of the lectin or prior incubation of the lectin with 200 mM of GalNAc (19) .
Immunohistochemistry
Paraffin-embedded blocks from AD and normal control brains were cut in 6-m-thick sections. Selected sections were labeled with the lectins, and monoclonal antibodies against human synaptophysin (MAB332, dilution 1:1,000; Chemicon International Inc., Temecula, CA), or PHF-tau hyperphosphorylated (6) (mAb AD2, dilution 1:500), or amyloid-␤ (mAb M087201, dilution 1:100; Dako Corporation, Carpinteria, CA). The monoclonal antibody AD2 (24) was kindly provided by Dr. Andre Delacourte (INSERM, Lille, France). Lectin binding was indirectly recognized with extravidin-FITC conjugated (Sigma). Primary antibodies were indirectly recognized by secondary antibodies Red X-conjugated (Jackson Immunoresearch, Hornby, Canada). In all cases, slides were pretreated in 80% formic acid for 5 min to enhance amyloid-␤ reactivity (6, 13) . Finally, the samples were washed and mounted with Vectashield (Vector Laboratories, Burlingame, CA). Double-labeled slides were viewed with an inverted NIKON microscope equipped with epiillumination and a Bio-Rad laser confocal system.
Tissue Localization of the ALL Receptor AD brain samples were fixed in 4% paraformaldehyde buffered solution and used to localize the ALL receptor with transmission electron microscopy (TEM) using gold particles of 20 nm. Tissue was dehydrated in crescent methyl alcohol concentrations beginning with 30% for 5 min at 4ЊC, 50% for 5 min at 4ЊC, followed by 70% and 90% for 5 min at Ϫ20ЊC, then embedded in Lowicryl K4M (Electron Microscopy Sciences, Fort Washington, PA), and 90% methyl alcohol (1:1) for 1 h. The resin concentration was increased to a 2:1 proportion for 1 h and followed by the use of pure Lowicryl resin overnight. The resin was polymerized in gelatin capsules under an ultraviolet lamp for 48 h at 4ЊC. The tissue was cut with glass knives to 60 to 120 nm and mounted on gold grids. Grids were washed successively in PBS-Ca ϩϩ for 5 min, incubated in PBS-2% Albumin IgG free (Sigma) for 30 min, washed in PBS-Ca ϩϩ and incubated with the biotinylated ALL lectin in PBS-Ca ϩϩ (dilution 1:50) for 2 h at 37ЊC in a humidified chamber, washed in PBS-Ca ϩϩ and incubated in extravidin-gold conjugated particles of 20 nm (Sigma) for 1 h at 37ЊC in a humidified chamber. Then, grids were washed again 3 times in PBS-Ca ϩϩ bi-distilled water for 5 min. Grids were only lightly contrasted in uranyl acetate (Merck, Darmstadt, Germany) for 5 min, finally washed, air dried, and observed under a TEM and photographed.
Cleavage of O-Glycans
Proteins were extracted from brain samples as follows: 500 mg of a frozen brain sample was placed in 5 ml of 30 mM phosphate buffer, pH 8.4 (PBS), containing 1 g/ml aprotinin A, 1 g/ml pepstatin, 2 g/ml leupeptin, 2 mM phenylmethylsulfonyl fluoride, 0.2% SDS, and 0.5% ␤-mercaptoethanol, then the tissue was boiled for 5 min at 100ЊC. Cell debris was removed by centrifugation for 30 min at 18,000 g, the pellets were eliminated, and the clear supernatant was kept at Ϫ70ЊC until use. Cleavage of glycosidically linked structures was performed in extracts containing 500 g of protein extracts per milliliter incubated overnight at 37ЊC with 80 mU of N-peptide glycosidase F (PNGase) (19) or at 37ЊC for 48 h with 1 mU of O-glycanase (19) . Brain extracts were then boiled for 1 min to stop the enzymatic treatment and further used for electrophoresis assays. Protein concentration was determined by the method of Bradford (25) , using bovine serum albumin as standard.
Protein Blotting
AD and control brain extracted proteins (100 g/each) were subjected to polyacrylamide gel electrophoresis (SDS-PAGE) in 12% separating and 4% stacking gels in a slab gel apparatus according to the method of Laemmli (26) . Coomassie brilliant blue R-250 was used for staining. Resolved proteins were transferred to nitrocellulose membranes using a semidry blotting apparatus (Bio-Rad) under conditions recommended by the manufacturer. Membranes containing transferred proteins were blocked overnight with TBS (Tris-base 20 mM, NaCl 137 mM, pH 7.6, and 0.1% Tween 20) and 5% skimmed milk, washed in TBS, and the ALL receptor was detected with ALL-biotin labeling (1 g/ml) and revealed with extravidin conjugated with horseradish peroxidase in an enhanced chemiluminescence detection system. Protein blotting was also performed using samples treated previously with PNGase or O-glycanase. Negative controls were performed using biotin-labeled antibodies raised against ALL, which revealed no interaction with brain protein extracts. Specificity of the interaction between ALL and brain extracts was assessed using ALL-biotin labeling, previously incubated with its specific sugar inhibitor (200 mM GalNAc), which revealed no interaction to the nitrocellulose-transferred proteins.
Amino Acid Sequencing
Amino acid sequencing of the identified 90-kDa glycoprotein from AD brain protein extracts was determined through MAL-DI-TOF in peptide fragments obtained by trypsin digestion. After electrophoresis on SDS-PAGE, the 90-kDa band was excised with a scalpel, electro-eluted using a model 422 electro-eluter (Bio-Rad), and electrophoresed again. The band containing 200 pM of protein was excised and incubated with 0.5 g trypsin using Promega sequencing grade (Promega, Madison, WI) in 500 l ammonium bicarbonate, pH 8.0, at 37ЊC for 24 h. The enzyme digest was evaporated to dryness using a Speed Vac concentrator (GMI, Inc., Albertville, MN) and re-evaporated with water (2 ϫ 100 l). Samples were prepared by mixing directly onto the target 1 l of the reaction products (containing 50 pM) and 1 l of a 2,5-dihydroxybenzoic acid matrix (12 mg/ml in acetonitrile/H 2 0, 80:20, v/v) and allowing the mixture to crystallize at room temperature. Positive ions of the peptides were measured by MALDI-TOF on a Vision 2000 time-of-flight mass spectrometer (Finnigan MAT, Bremen, Germany) equipped with a 337 nm UV laser. The mass spectra were acquired in reflectron mode under 8 keV acceleration voltage and positive detection. Control assays were performed using trypsin alone to identify self-digested peptide mass and with angiotensin I as standard (Mr 1296.7) (27) 
RESULTS

Diagnostic
The use of ALL, a GalNAc-specific lectin, allowed us to find a particular glycosylation pattern linked to sprouting mechanisms, characterized particularly by the presence of meganeurites reactive to AD2 (Fig. 1A) and to synaptophysin (Fig. 1B) in AD. Double labeling with ALL and AD2 or synaptophysin or amyloid-␤ in these lesions identified the neuronal nature of the glycosylated meganeurites ( Fig. 2A-D) . Analysis with FITC-ALL in double-labeled AD tissue slides in confocal microscopy showed a consistent lectin binding in meganeurites in AD, whereas only vessels bound lectins in normal nondemented control brains (not shown). In all cases, amyloid-␤ deposits were observed and constituted as a core (c) and related to meganeurites ( Fig. 2A, C, D) .
Protein Blotting
As determined by SDS-polyacrylamide electrophoresis and Western blot analysis (Fig. 3) , the fraction recognized by ALL is a 90-kDa glycoprotein (further termed as 90Azgp). Because incubation of ALL with 200 mM of GalNAc for 30 min prior to Western blot analysis yielded negative results and no bands were revealed, the specificity of the interaction of ALL with the 90Azgp was determined by hapten inhibition assays. The glycosidic nature of this fraction was confirmed by the fact that treatment with the O-glycanase from D. pneumoniae, but not PNGase treatment, abolished its recognition by ALL in protein blotting analysis (not shown).
Amino Acid Sequence
Amino acid sequence of the 90Azgp was analyzed from peptides obtained after trypsin digestion by MAL-DI-TOF and compared with the relative values obtained from the NCBInr (Swiss-Prot 10/01/99) database. Digestion of the glycoprotein with trypsin yielded 11 peptides with an m/z range of 634 to 2379. When we compared the m/z values with the relative values obtained from the NCBInr database, a homology of 32% with a KIAA0310 protein from human brain and a 42% homology with the protein from human gastric mucin were found (Table) . Glycosylation sites determined by the NetOGlyc 2.0 pattern search indicated that the 90Azgp showed no putative N-glycosylation sites; whereas, serine residues at positions 5, 65, and 67 of predicted sequence showed to be O-glycosylated (Table) .
Transmission Electron Microscopy
TEM of postmortem AD tissue revealed a particular distribution of the gold particles in the tissue. Figure 1C demonstrates a specific gold labeling observed in AD neurons. Consistently, particles were distributed more densely at the end or immediately after the rough endoplasmic reticulum, particularly clustered in vesicles. Under high magnification, the bulk of gold particles was seen to lay directly in vesicles or cavities of the remnant Golgi cisterns at the edge of the rough endoplasmic reticulum (Fig. 1C) . Gold-labeled particles were more often observed in intracellular large cavities. In contrast, no labeling was found directly in the rough endoplasmic reticulum (Fig. 1C) .
DISCUSSION
Neurofibrillary tangles, neuritic plaques, and neuronal loss are the main neuropathological features of AD (21, 22, 28) . Several studies have suggested that post-translational modifications of proteins, such as glycosylation, could be correlated with specific alterations of AD as well as with other neurodegenerative encephalopathies (6, 13, 29, 30) . Previous works have shown that the labeled GalNAc-specific ALL co-localizes with antibodies against ß-amyloid in neuritic plaques as well as in sprouting meganeurites (6, 13) , suggesting the active participation of O-glycosidically linked proteins in AD. In this work, we identified a 90-kDa glycoprotein that is recognized by ALL (90Azgp) and characterized its amino acid sequence by analyzing the peptides obtained after trypsin digestion through MALDI-TOF and comparing them with the relative values obtained from the NCBInr database.
Our results revealed that 90Azgp depicts different rates of homology with 2 main glycoproteins: KIAA0310 (32%) and the human gastric mucin (42%). KIAA genes correspond to a group of proteins that seems to be related to cell signaling/communication, nucleic acid management, and cell structure/motility. The expression profiles of these genes in 14 different tissues have been analyzed by RT-PCR, and 8 genes were found predominantly expressed in the brain (31) . Our data also indicate that the 90Azgp showed homology with human gastric mucin, a highly glycosylated protein characteristically composed by tandem repeat sequences (15, 34) . It has been shown that many glycoproteins containing O-glycosidically linked glycans (conforming mucin and mucin-like structures) play important roles in modulating the immune response, inflammation, and tumor genesis (15, (32) (33) (34) , since they are responsible for the 3-dimensional organization of many glycoproteins (15, 34) .
The ability of lectins to bind carbohydrate structures found in glycoconjugates depends on their 3-dimensional structure (35, 36) . In the presence of glycoproteins containing O-glycosidically linked glycans, the specificity of ALL is directed to the inner core of class I O-glycosidically linked glycans containing Gal ␤1-3 GalNAc␣1-0Ser/Thr and GalNAc␣1-0Ser/Thr (18) , but a specific distance among the O-glycosylable sites is the determinant for ALL specificity (37) . This indicates that mucin-type sequences are present in neuritic plaques. The specific role of this mucin-like receptor identified by ALL in AD brains has not yet been identified; however, since the 90Azgp was expressed in the Golgi apparatus of AD pathologic neurons (as demonstrated by TEM), it is possible that this receptor could interact with the Gal receptor reported in other cellular groups. The neuritic plaques formed by an amyloid-␤ deposit are surrounded by dystrophic neurites, reactive astrocytes, and microglia (3, 7, 38) . Microglia, the tissue macrophages of the brain, play a crucial role in recognition and phagocytic removal of apoptotic neurons, and although the microglial receptors for recognition of apoptotic neurons are not yet characterized, some reports suggest that the uptake of apoptotic neurons involves asialoglycoprotein lectin (39) . Recent data suggest that specific interaction through O-glycosidically linked glycans on the surface of phagocytic cells could alter the organization of microtubules and microfilaments, which, in the case of microglia, might be considered as a specific signal to release trophic factors that also participate in the formation of neurites (40) . NetOGlyc 2.0 pattern searches indicated the absence of putative N-glycosylation sites in the 90Azgp, whereas, serine residues at positions 5, 65, and 67 of predicted sequence were shown to be O-glycosylated. O-glycosylation of the specific receptor for ALL in AD brains was confirmed by treating the glycoprotein brain extracts with an O-glycanase or the PNGase, specific for N-glycans (results showed that only O-glycanase abolished ALL interaction). As for other glycoproteins, 90Azgp seems to mature within the trans-Golgi network. This glycoprotein was identified by indirect positive labeling of ALL receptors with gold particles packaged into vesicles for trafficking through the late secretory pathway into Golgi and trans-Golgi network (41) (42) (43) (44) . Further characterization of the 90-kDa glycoprotein described in this work and its
